Back to HomeBeta

ICD-10 Coding for Laryngeal Squamous Cell Carcinoma(C32.8, C32.0)

Complete ICD-10-CM coding and documentation guide for Laryngeal Squamous Cell Carcinoma. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Laryngeal SCCVoice Box Cancer

Quick Navigation

Related ICD-10 Code Ranges

Complete code families applicable to Laryngeal Squamous Cell Carcinoma

C32.0-C32.9Primary Range

Malignant neoplasm of larynx

This range covers all malignant neoplasms of the larynx, including site-specific and overlapping site codes.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
C32.8Malignant neoplasm of overlapping sites of larynxUse when the tumor involves two or more subsites of the larynx, such as glottis and supraglottis.
  • Biopsy-confirmed squamous cell carcinoma
  • Imaging showing tumor involving multiple laryngeal subsites
C32.0Malignant neoplasm of glottisUse when the tumor is confined to the glottis.
  • Biopsy-confirmed squamous cell carcinoma
  • Tumor confined to the glottis

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for laryngeal squamous cell carcinoma

Essential facts and insights about Laryngeal Squamous Cell Carcinoma

The ICD-10 code for laryngeal squamous cell carcinoma involving overlapping sites is C32.8.

Primary ICD-10-CM Codes for laryngeal squamous cell carcinoma

C32.8
Malignant neoplasm of overlapping sites of larynx
Billable Code

Decision Criteria

clinical Criteria

  • Tumor involves multiple laryngeal subsites

Applicable To

  • Transglottic carcinoma

Excludes

  • Benign laryngeal neoplasm (D14.1)

Clinical Validation Requirements

  • Biopsy-confirmed squamous cell carcinoma
  • Imaging showing tumor involving multiple laryngeal subsites

Code-Specific Risks

  • Incorrectly coding as C32.9 (unspecified) when subsites are documented

Coding Notes

  • Ensure documentation specifies overlapping sites to justify C32.8.
View Full Code Details

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Personal history of malignant neoplasm of larynx

Z85.21
Use for follow-up visits post-treatment.

Dysphonia

R49.0
Use for associated symptoms like voice changes.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Malignant neoplasm of oropharynx, unspecified

C10.9
Differentiate based on tumor location; laryngeal tumors are not coded under oropharyngeal codes.

Malignant neoplasm of supraglottis

C32.1
Differentiate based on tumor location; glottic tumors are not coded under supraglottic codes.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Laryngeal Squamous Cell Carcinoma to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C32.8.

Impact

Clinical: May lead to inappropriate treatment planning., Regulatory: Non-compliance with coding standards., Financial: Potential for incorrect billing and reimbursement.

Mitigation Strategy

Use detailed anatomical descriptions, Implement standardized reporting templates

Impact

Reimbursement: May lead to incorrect DRG assignment and reimbursement issues., Compliance: Non-compliance with coding guidelines., Data Quality: Impacts the accuracy of cancer registry data.

Mitigation Strategy

Use specific codes like C32.8 when subsites are involved.

Impact

Failure to document specific laryngeal subsites can lead to audit findings.

Mitigation Strategy

Use detailed anatomical descriptions and synoptic templates.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Laryngeal Squamous Cell Carcinoma, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Laryngeal Squamous Cell Carcinoma

Use these documentation templates to ensure complete and accurate documentation for Laryngeal Squamous Cell Carcinoma. These templates include all required elements for proper coding and billing.

Pathology Report for Laryngeal SCC

Specialty: Pathology

Required Elements

  • Specimen type
  • Tumor site
  • Histology
  • Tumor size
  • Margins
  • Lymphovascular invasion
  • Perineural invasion
  • pTNM stage

Example Documentation

SPECIMEN: Total laryngectomy TUMOR SITE: Glottis and supraglottis (transglottic) HISTOLOGY: Moderately differentiated keratinizing squamous cell carcinoma SIZE: 3.2 cm greatest dimension MARGINS: Anterior: 1 mm (positive) LYMPHOVASCULAR INVASION: Present pTNM: pT3 pN1 (2/15 nodes positive)

Examples: Poor vs. Good Documentation

Poor Documentation Example
Cancer found in voice box, treated with surgery.
Good Documentation Example
Stage IVA (pT4aN2bM0) transglottic squamous cell carcinoma with cartilage invasion, negative EBER-ISH, treated with total laryngectomy and bilateral neck dissection. Margins clear (3 mm closest).
Explanation
The good example provides detailed staging, histological findings, and treatment details, improving clinical clarity and coding accuracy.

Need help with ICD-10 coding for Laryngeal Squamous Cell Carcinoma? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more

Helpful Links

How ICD 10 AI Lookup WorksContact UsPrivacy Policy